Epidemiology and Relative Severity of Influenza Subtypes in Singapore in the Post-Pandemic Period from 2009 to 2010

Clinical Infectious Diseases

Volumn 65, Issue 11, 2017, Pages 1905-1913

  Goh, Ee Hui ^a   Jiang, Lili ^a   Hsu, Jung Pu ^a,b   Tan, Linda Wei Lin ^a   Lim, Wei Yen ^a   Phoon, Meng Chee ^c   Leo, Yee Sin ^b   Barr, Ian G ^d   Chow, Vincent Tak Kwong ^c   Lee, Vernon J ^a,e   Lin, Cui ^f   Lin, Raymond ^c,f   Sadarangani, Sapna P ^b   Young, Barnaby ^b   Chen, Mark I Cheng ^a,b  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b TAN TOCK SENG HOSPITAL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^e Biodefence Center   (Singapore)

^f MINISTRY OF HEALTH   (Singapore)

Author keywords

birth cohort effect; cross protection; H1N1pdm09; seroepidemiology; severity

Indexed keywords

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION RISK; INFLUENZA; INFLUENZA A (H3N2); MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SINGAPORE; YOUNG ADULT; BLOOD; CROSS PROTECTION; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); PANDEMIC; RISK FACTOR; SEASON; SEVERITY OF ILLNESS INDEX; VACCINATION; VIROLOGY;

INFLUENZA VACCINE; VIRUS ANTIBODY;

ADULT; AGE FACTORS; AGED; ANTIBODIES, VIRAL; CROSS PROTECTION; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PANDEMICS; RISK FACTORS; SEASONS; SEVERITY OF ILLNESS INDEX; SINGAPORE; VACCINATION; YOUNG ADULT;

EID: 85034849608     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix694     Document Type: Article

References (39)

1. World Health Organization. Swine Influenza 2009 (31 March 2015). Available from: http://www.who.int/mediacentre/news/statements/2009/h1n1-20090425/ en/. Accessed 31 March 2015.
2. Mukherjee P, Lim P, Chow A, et al. Epidemiology of travel-associated pandemic (H1N1) 2009 infection in 116 patients, Singapore. Electr J Surg 2010; 16:21-6.161.
3. Ong JBS, Chen MIC, Cook AR, et al. Real-time epidemic monitoring and forecasting of H1N1-2009 using influenza-like illness from general practice and family doctor clinics in Singapore. PLoS ONE 2010; 5:e10036-e.54.
4. Tay J, Ng YF, Cutter J, James L. Influenza A (H1n1-2009) pandemic in Singapore-public health control measures implemented and lessons learnt. Ann Acad Med Singapore 2010; 39:313-12.394.
5. Win MK, Chen MI, Barkham T, et al. Influenza disease burden in adults by subtypes following the initial epidemic of pandemic H1N1 in Singapore. Influenza Other Respir Viruses 2011; 5:e563-7.
6. Palese P, Wang TT. Why do influenza virus subtypes die out? A hypothesis. MBio 2011; 2:e00150-11.25.
7. Epstein SL. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis 2006; 193:49-53.
8. Slepushkin A. The effect of a previous attack of A1 influenza on susceptibility to A2 virus during the 1957 outbreak. Bull World Health Organ 1959; 20:297.202-3.
9. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998; 178:53-60.
10. Saglanmak N, Andreasen V, Simonsen L, Mølbak K, Miller MA, Viboud C. Gradual changes in the age distribution of excess deaths in the years following the 1918 influenza pandemic in Copenhagen: using epidemiological evidence to detect antigenic drift. Vaccine 2011; 29:B42-B8.29.
11. Hernandez JE, Grainger J, Simonsen L, Collis P, Edelman L, Sheridan WP. Impact of the 2009/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment. Influenza and Other Respir Viruses 2012; 6:305-8.65.
12. Shrestha SS, Swerdlow DL, Borse RH, et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis 2011; 52:S75-S82.52.
13. National University of Singapore. Singapore Population Health Study (10 August 2016). Available at: https://www.sph.nus.edu.sg/research/sphs.
14. Lim W-Y, Chen C, Ma Y, et al. Risk factors for pandemic (H1N1) 2009 seroconversion among adults, Singapore, 2009. Emerg Infect Dis 2011; 17:1455-62.178.
15. Chen MI, Cook AR, Lim WY, et al. Factors influencing infection by pandemic influenza A(H1N1)pdm09 over three epidemic waves in Singapore. Influenza Other Respir Viruses 2013; 7:1380-9.
16. Chen MI, Barr IG, Koh GC, et al. Serological response in RT-PCR confirmed H1N1-2009 influenza a by hemagglutination inhibition and virus neutralization assays: an observational study. PLoS One 2010; 5:e12474.58.
17. Kendal A, Skehel J, Pereira M. World Health Organization Collaborating Centers for Reference and Research on Influenza: concepts and procedures for laboratory-based influenza surveillance. Atlanta, GA: World Health Organization Collaborating Centers for Reference and Research in Influenza, Centers for Disease Control B17-B35 p. 1982.
18. World Health Organization. Recommendations for Influenza Vaccine Composition (6 October 2015). Available at: http://www.who.int/influenza/ vaccines/vaccinerecommendations1/en/.
19. Singapore Ministry of Health. Communicable Diseases Surveillance in Singapore 2010. 2010:10 (12 January 2016). Available from: https://www.moh.gov.sg/content/ dam/moh-web/Publications/Reports/2011/Communicable%20Diseases%20 Surveillance%20in%20Singapore%202010/Air%20droplet-born%202010.pdf.
20. R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2015.
21. Lee VJ, Chen MI, Chan SP, et al. Influenza pandemics in Singapore, a tropical, globally connected city. Emerg Infect Dis 2007; 13:1052-7.
22. Lee VJ, Wong CS, Tambyah PA, Cutter J, Chen MI, Goh KT. Twentieth century influenza pandemics in Singapore. Ann Acad Med Singapore 2008; 37:470-6.
23. Soh SE, Cook AR, Chen MI, et al. Teacher led school-based surveillance can allow accurate tracking of emerging infectious diseases-evidence from serial cross-sectional surveys of febrile respiratory illness during the H1N1 2009 influenza pandemic in Singapore. BMC Infectious Diseases 2012; 12:336.121.
24. Chen MI, Lee VJ, Barr I, et al. Risk factors for pandemic (H1N1) 2009 virus seroconversion among hospital staff, Singapore. Emerg Infect Dis 2010; 16:1554.1610.
25. Viboud C, Boëlle PY, Cauchemez S, et al. Risk factors of influenza transmission in households. Br J Gen Pract 2004; 54:684-9.
26. Lee VJ, Yap J, Ong JB, et al. Influenza excess mortality from 1950-2000 in tropical Singapore. PLoS One 2009; 4:e8096.412.
27. Ferguson NM, Galvani AP, Bush RM. Ecological and immunological determinants of influenza evolution. Nature 2003; 422:428-33.4226930.
28. Hayward AC, Wang L, Goonetilleke N, et al; Flu Watch Group. Natural T cell-mediated protection against seasonal and pandemic influenza. Results of the Flu Watch Cohort study. Am J Respir Crit Care Med 2015; 191:1422-31.
29. Hsu J, Phoon M, Koh GC, et al. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers. Int J Infect Dis 2012; 16:e621-e7.168.
30. Lee CX, Poh WP, Sakharkar KR, Sakharkar MKI, Chow VTK. Differences between predicted cytotoxic T-lymphocyte epitopes of 2009 H1N1 swine-origin influenza virus compared with other H1N1 strains of 1918, 1934 and 2007 for HLA-A0201, HLA∗1101, n HLA-A2402 alleles: clinical implications. Int J Integr Biol 2010; 10: 124-31.103.
31. Pica N, Hai R, Krammer F, et al. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc Natl Acad Sci U S A 2012; 109:2573-8.1097.
32. Lee VJ, Tay JK, Chen MI, et al. Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains. Vaccine 2010; 28:6852-7.2842.
33. Kelly H, Barry S, Laurie K, Mercer G. Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non-specific temporary immunity following infection. Challenge 2010; 16:1716
34. Linde A, Rotzen-Ostlund M, Zweygberg-Wirgart B, Rubinova S, Brytting M. Does viral interference affect spread of influenza? Euro Surveill 2009;14:pii: 19354.1440.
35. Fonville JM, Wilks SH, James SL, et al. Antibody landscapes after influenza virus infection or vaccination. Science 2014; 346:996-1000.
36. Francis T. On the doctrine of original antigenic sin. Proc Am Philos Soc 1960; 104:572-8.1046.
37. Ferdinands JM, Fry AM, Reynolds S, et al. Intraseason waning of influenza vaccine protection: evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15. Clin Infect Dis 2017; 64:544-50.
38. Cauchemez S, Horby P, Fox A, et al. Influenza infection rates, measurement errors and the interpretation of paired serology. PLoS Pathog 2012; 8:e1003061.
39. Hsu JP, Zhao X, Mark I, et al. Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore. BMC Infect Dis 2014; 14:414.141.